{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "2020T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutated LRRK2 exhibits higher susceptibility to post-translational degradation than the wild-type LRRK2, impairing the protective effect against hydrogen peroxide-induced apoptosis. This degradation contributes to neurodegeneration.",
          "judgment": "Yes",
          "reasoning": "The abstract and introduction clearly state the core mechanism: the I2020T mutation increases susceptibility to degradation, leading to impaired protection against apoptosis, which is a key aspect of PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study utilizes a cell phenotype rescue assay – measuring apoptosis protection against hydrogen peroxide – a standard approach for assessing the functional impact of LRRK2 mutations.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly describes using a cell phenotype rescue assay (apoptosis protection), which is a commonly accepted method for evaluating LRRK2 mutations in PD research.",
          "next_step_or_outcome": "Proceed to Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The study demonstrates that the I2020T mutation impairs apoptosis protection, a crucial aspect of PD pathogenesis, through a cell-based assay. This, coupled with the known susceptibility to degradation, supports a pathogenic designation (PS3)."
    }
  ]
}